Difference between revisions of "Lumiere Biologics/Infobox"
Jump to navigation
Jump to search
imported>Sub-Pulse |
imported>Sub-Pulse |
||
| Line 1: | Line 1: | ||
{| align="center" | {| align="center" | ||
|- | |- | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| '''Financial Profile:''' | | '''Financial Profile:''' | ||
| The Ueda Family, specifically Dr. Hideki Ueda, are Majority Shareholders of Lumiere Biologics's IPO, the shares are divided along lines of Class A and Class B shares with Class A shares equaling 10 votes to the value of 1 in the case of a Class B. Almost all of the control in the hands of the C.E.O. who remains invested in the daily activities. That said there is a board of directors which has been appointed to handle various facets of the company. | | The Ueda Family, specifically Dr. Hideki Ueda, are Majority Shareholders of Lumiere Biologics's IPO, the shares are divided along lines of Class A and Class B shares with Class A shares equaling 10 votes to the value of 1 in the case of a Class B. Almost all of the control in the hands of the C.E.O. who remains invested in the daily activities. That said there is a board of directors which has been appointed to handle various facets of the company. | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 18:28, 30 September 2014
| Financial Profile: | The Ueda Family, specifically Dr. Hideki Ueda, are Majority Shareholders of Lumiere Biologics's IPO, the shares are divided along lines of Class A and Class B shares with Class A shares equaling 10 votes to the value of 1 in the case of a Class B. Almost all of the control in the hands of the C.E.O. who remains invested in the daily activities. That said there is a board of directors which has been appointed to handle various facets of the company. |
